ABD-3001 clinical trials

First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients

This study is testing a new medicine, ABD-3001, for adults with certain types of leukaemia (AML) or bone marrow conditions (MDS) that haven't responded to other treatments. It will check if the medicine is safe, how much can be given, and if it shows early signs of helping.